Newsroom - Page 3 - Biome Diagnostics | BiomeDx

Publications & Posters

UEG 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening tool

Catia PacificoOctober 11, 2022

Poster: World Congress of Lung Cancer 2022

VIENNA, October 5th: The World Congress of Lung Cancer is the world's largest international gathering…

Barbara SladekOctober 5, 2022

Publications & Posters

Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)

Catia PacificoOctober 1, 2022

Publications & Posters

ÖGP 2022: Prediction of immune checkpoint inhibitor response in non-small cell lung cancer patients using a microbiome-based biomarker

Catia PacificoOctober 1, 2022

FFG Entrepreneurship Day 2022

Founding your own business VIENNA, September 2022 Startups, spin-offs and entrepreneurs met in the Kursalon…

Catia PacificoSeptember 30, 2022

Poster: 14th ÖGMBT Annual Meeting

VIENNA, September 26th: BiomeDx presented last week at the ÖGMBT (https://oegmbt.at/events/annual-meeting) in Vienna the poster…

Catia PacificoSeptember 26, 2022

Publications & Posters

ÖGMBT 2022: Deconfounding the intestinal microbiome signature of responders versus non- responders to immune checkpoint inhibitor therapies

Catia PacificoSeptember 26, 2022

FMT Conference Copenhagen

Gut microbiota modulation in health and disease - faecal microbiota transplantation and beyond VIENNA, September…

Catia PacificoSeptember 19, 2022

Publications & Posters

ESMO 2022: BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy

Catia PacificoSeptember 19, 2022

Poster: ESMO Congress 2022

BiomeDx presents multi-centric validation of BiomeOne® at the ESMO Congress 2022 VIENNA, September 19th: The…

Catia PacificoSeptember 19, 2022

Previous 1 2 3 4 5 … 7 Next